Top Stories

Biosimilar drugs breaking high-cost barrier to cancer immunotherapy

Times of india·24 Oct 2026
Biosimilar drugs breaking high-cost barrier to cancer immunotherapy

Recent changes in cancer care in India show an increase in immunotherapy prescriptions due to affordable biosimilars. Doctors report that the availability of cheaper versions of nivolumab has…

More news in Top Stories